Ep.115 – Septic Shock and AKI: Do we still need to worry about piperacillin-tazobactam?
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Ep.115 – Septic Shock and AKI: Do we still need to worry about piperacillin-tazobactam?
-
Narrated by:
-
By:
About this listen
In this episode of the DASON Digest podcast, DASON clinical pharmacist liaison Dr. Angelina Davis talks with us about a national retrospective cohort study comparing the effects of cefepime versus piperacillin-tazobactam on the development of severe acute kidney injury in patients with septic shock. The article for this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39657005/
For more information about DASON, please visit: https://dason.medicine.duke.edu/
What listeners say about Ep.115 – Septic Shock and AKI: Do we still need to worry about piperacillin-tazobactam?
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.